Company has spent 2.61% of its operating revenues towards interest expenses and 17.47% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Praveg Comm - Praveg Share Price
Praveg Comm - Praveg Sh...
Praveg Comm share price insights
Stock gave a 3 year return of 988.07% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock generated 988.07% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Praveg Ltd. share price moved up by 0.08% from its previous close of Rs 816.05. Praveg Ltd. stock last traded price is 816.75
Share Price Value Today/Current/Last 816.75 Previous Day 816.05
Key Metrics
PE Ratio (x) | 161.29 | ||||||||||
EPS - TTM (₹) | 5.03 | ||||||||||
MCap (₹ Cr.) | 2,092.52 | ||||||||||
Sectoral MCap Rank | 65 | ||||||||||
PB Ratio (x) | 7.32 | ||||||||||
Div Yield (%) | 0.12 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| -0.09 | ||||||||||
VWAP (₹) | 821.57 | ||||||||||
52W H/L (₹) |
Praveg Comm Share Price Returns
1 Day | -0.7% |
1 Week | 0.38% |
1 Month | -4.09% |
3 Months | -15.6% |
1 Year | 71.95% |
3 Years | 710.3% |
5 Years | 11122.99% |
Praveg Comm News & Analysis
Warning signs flash for over 100 smallcap multibaggers. Is it a bubble waiting to burst?
NewsSmallcap stock rallies 5% after FM mentions Lakshadweep in Budget speech
NewsRam Mandir theme: Smallcap zooms 7% on bagging orders from Ayodhya
NewsAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcements
Praveg Comm Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Praveg Comm Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent 2.61% of its operating revenues towards interest expenses and 17.47% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Quarterly | Annual Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Total Income 33.50 33.97 14.64 12.45 19.00 Total Income Growth (%) -1.40 132.07 17.62 -34.50 -33.26 Total Expenses 25.38 24.54 12.43 10.75 11.34 Total Expenses Growth (%) 3.39 97.50 15.65 -5.23 -11.47 EBIT 8.12 9.43 2.21 1.70 7.66 EBIT Growth (%) -13.87 326.27 30.13 -77.81 -51.08 Profit after Tax (PAT) 1.64 8.10 2.10 1.17 5.17 PAT Growth (%) -79.75 286.47 79.36 -77.41 -55.25 EBIT Margin (%) 24.25 27.76 15.11 13.66 40.32 Net Profit Margin (%) 4.89 23.83 14.31 9.39 27.22 Basic EPS (₹) 0.73 3.56 0.98 0.53 2.68 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 364.59 125.61 37.88 26.98 24.87 Total Assets Growth (%) 190.25 231.59 40.40 8.51 15.77 Total Liabilities 76.75 13.15 10.28 7.92 9.91 Total Liabilities Growth (%) 483.61 27.94 29.72 -20.07 2.26 Total Equity 287.84 112.46 27.60 19.06 14.95 Total Equity Growth (%) 155.94 307.43 44.84 27.46 26.88 Current Ratio (x) 12.43 4.93 2.57 3.87 2.42 Total Debt to Equity (x) 0.00 0.00 0.12 0.05 0.06 Contingent Liabilities 0.00 10.03 5.85 4.26 4.30 All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 177.87 cr for investing activities which is an YoY increase of 145.01%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 17.04 25.27 6.61 15.20 5.89 Net Cash used in Investing Activities -177.87 -72.60 -12.91 -0.49 -0.62 Net Cash flow from Financing Activities 220.33 52.06 -2.46 -8.34 -3.12 Net Cash Flow 59.50 4.73 -8.75 6.37 2.15 Closing Cash & Cash Equivalent 64.40 4.90 0.39 9.14 2.77 Closing Cash & Cash Equivalent Growth (%) 1,213.77 1,149.16 -95.71 229.97 345.42 Total Debt/ CFO (x) 0.00 0.02 0.50 0.06 0.16 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 4.51 25.28 44.35 56.35 24.58 Return on Capital Employed (%) 6.08 34.55 57.67 67.45 35.88 Return on Assets (%) 3.56 22.63 32.31 39.80 14.67 Interest Coverage Ratio (x) 13.45 65.62 39.45 48.52 12.41 Asset Turnover Ratio (x) 0.37 1.03 1.40 1.75 2.57 Price to Earnings (x) 188.68 34.25 20.45 11.15 4.59 Price to Book (x) 8.44 8.66 9.07 6.28 1.13 EV/EBITDA (x) 72.39 21.00 12.81 6.85 2.18 EBITDA Margin (%) 35.09 53.62 43.66 35.83 11.32
Praveg Comm Peer Comparison
Praveg Comm Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 988.07% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 988.07% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 988.07% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 988.07% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Praveg Comm Board Meeting/AGM
Praveg Comm Dividends
- Others
Meeting Date Announced on Purpose Details May 27, 2024 May 21, 2024 Board Meeting Audited Results & Final Dividend Apr 04, 2024 Apr 01, 2024 Board Meeting Preferential issue of shares Feb 13, 2024 Feb 05, 2024 Board Meeting Quarterly Results Jan 23, 2024 Dec 29, 2023 EGM - Nov 09, 2023 Nov 02, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 45% 4.5 Sep 15, 2023 May 30, 2023 Final 40% 4.0 Nov 21, 2022 May 24, 2022 Final 20% 2.0 Jul 15, 2021 Jun 10, 2021 Interim 20% 2.0 Feb 15, 2021 Feb 01, 2021 Final 10% 1.0 - May 27, 2024 All Types Ex-Date Record Date Announced on Details Splits - - Aug 21, 2001 Split: Old FV10.0| New FV:1.0
About Praveg Comm
Praveg Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 2,107.50 Crore) operating in Pharmaceuticals sector. Praveg Ltd. key Products/Revenue Segments include Sale of services and Other Operating Revenue for the year ending 31-Mar-2023. Show More
Executives
Auditors
- VP
Vishnukumar Patel
Chairman & Non-Exe.DirectorPPParaskumar Patel
Managing DirectorBPBhumit Patel
Executive DirectorBPBijal Parikh
Executive DirectorShow More - B K Patel & Co.
Industry
Key Indices Listed on
BSE SmallCap, BSE Consumer Discretionary, BSE AllCap, + 1 more
Address
214, Athena Avenue,Behind Jaguar Showroom,S. G. Highway, Gota,Ahmedabad, Gujarat - 382481
More Details
FAQs about Praveg Comm share
- 1. What is Praveg Comm share price and what are the returns for Praveg Comm share?Praveg Comm share price was Rs 810.30 as on 18 Jul, 2024, 10:32 AM IST. Praveg Comm share price was down by 0.70% based on previous share price of Rs. 771.65. In last 1 Month, Praveg Comm share price moved down by 4.09%.
- 2. Is Praveg Comm giving dividend?An equity Final dividend of Rs 4.5 per share was declared by Praveg Ltd. on 30 May 2023. So, company has declared a dividend of 45% on face value of Rs 10 per share. The ex dividend date was 15 Sep 2023.
- 3. Who's the chairman of Praveg Comm?Vishnukumar Patel is the Chairman & Non-Exe.Director of Praveg Comm
- 4. Who's the owner of Praveg Comm?Following are the key changes to Praveg Comm shareholding:
- Promoter holding have gone down from 55.01 (30 Sep 2023) to 45.97 (30 Jun 2024)
- Foreign Institutional Investors holding has gone up from 5.14 (30 Sep 2023) to 9.02 (30 Jun 2024)
- Other investor holding has gone up from 39.85 (30 Sep 2023) to 40.16 (30 Jun 2024)
- 5. What is the PE & PB ratio of Praveg Comm?The PE ratio of Praveg Comm stands at 162.12, while the PB ratio is 6.96.
- 6. What is the market cap of Praveg Comm?Praveg Comm share has a market capitalization of Rs 2,092.52 Cr. Within Pharmaceuticals sector, it's market cap rank is 65.
- 7. What has been highest price of Praveg Comm share in last 52 weeks?52 Week high of Praveg Comm share is Rs 1,300.00 while 52 week low is Rs 450.00
- 8. What are the Praveg Comm quarterly results?Total Revenue and Earning for Praveg Comm for the year ending 2024-03-31 was Rs 94.55 Cr and Rs 13.00 Cr on Consolidated basis. Last Quarter 2024-03-31, Praveg Comm reported an income of Rs 33.50 Cr and profit of Rs 1.64 Cr.
- 9. What are the key metrics to analyse Praveg Comm Share Price?Key Metrics for Praveg Comm are:
- PE Ratio of Praveg Comm is 161.29
- Price/Sales ratio of Praveg Comm is 26.53
- Price to Book ratio of Praveg Comm is 7.32
- 10. What is the CAGR of Praveg Comm?The CAGR of Praveg Comm is 19.24.
- 11. Who are the peers for Praveg Comm in Pharmaceuticals sector?Top 10 Peers for Praveg Comm are NGL Fine - Chem Ltd., SMS Pharmaceuticals Ltd., Themis Medicare Ltd., Amrutanjan Health Care Ltd., Syncom Formulation (India) Ltd., Solara Active Pharma Sciences Ltd., Lincoln Pharmaceuticals Ltd., IOL Chemicals and Pharmaceuticals Ltd., Kopran Ltd. and Bliss GVS Pharma Ltd.
- 12. What are the returns for Praveg Comm share?Return Performance of Praveg Comm Shares:
- 1 Week: Praveg Comm share price moved up by 0.38%
- 1 Month: Praveg Comm share price moved down by 4.09%
- 3 Month: Praveg Comm share price moved down by 15.60%
- 6 Month: Praveg Comm share price moved down by 26.31%
Trending in Markets
Praveg Comm Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.